Immunocore Holdings plc - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
IMCR Nasdaq 2836 www.immunocore.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Immunocore Holdings plc

How The Narrative Around Immunocore Holdings (IMCR) Is Shifting With New Data And Street Targets - Jan 10th, 2026 8:14 am
Immunocore announces 2026 strategic priorities at 44th Annual J.P. Morgan Healthcare Conference - Jan 9th, 2026 5:00 am
Immunocore (IMCR) Upgraded to Strong Buy: Here's What You Should Know - Jan 8th, 2026 10:00 am
Immunocore Holdings plc (IMCR) Asserts Pipeline Development and Strong Commercial Performance - Dec 8th, 2025 10:20 pm
Immunocore to present at upcoming investor conferences - Nov 10th, 2025 5:00 am
Immunocore Holdings plc (NASDAQ:IMCR) Just Reported Third-Quarter Earnings: Have Analysts Changed Their Mind On The Stock? - Nov 9th, 2025 5:54 am
Immunocore presents Phase 1 data for hepatitis B candidate at AASLD’s The Liver Meeting - Nov 7th, 2025 6:00 am
Will Strong Revenue Growth but Narrowed Profits Shift Immunocore Holdings' (IMCR) Investment Story? - Nov 6th, 2025 9:37 pm
Immunocore (IMCR) Reports Q3 Earnings: What Key Metrics Have to Say - Nov 6th, 2025 8:00 am
Immunocore reports third quarter financial results and provides a business update - Nov 6th, 2025 5:00 am
Recursion Pharmaceuticals to Report Q3 Earnings: What's in the Cards? - Nov 3rd, 2025 9:19 am
Apple upgraded, Comcast downgraded: Wall Street's top analyst calls - Oct 31st, 2025 7:33 am
H.C. Wainwright Remains Bullish on Immunocore Holdings plc (IMCR) - Oct 20th, 2025 9:08 pm
Assessing Immunocore Holdings (NasdaqGS:IMCR) Valuation Following Recent Share Price Momentum - Sep 14th, 2025 6:24 am
IOVA Q2 Earnings Miss, Stock Down on EMA Filing Withdrawal for Amtagvi - Aug 8th, 2025 10:47 am
Intellia Q2 Loss Narrower Than Expected, Pipeline Progress in Focus - Aug 8th, 2025 9:19 am
Immunocore Holdings PLC (IMCR) Q2 2025 Earnings Call Highlights: Strong Revenue Growth and ... - Aug 8th, 2025 9:01 am
PBYI's Q2 Earnings Beat Estimates, Nerlynx Sales Drive Revenues - Aug 8th, 2025 8:26 am
MIRM Stock Up on Q2 Earnings and Revenue Beat, Raised 2025 View - Aug 7th, 2025 9:20 am
Catalyst Pharmaceuticals Q2 Earnings Beat, Firdapse Revenues Rise Y/Y - Aug 7th, 2025 8:08 am